Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-28 Principi Anthony Director Exercise or conversion +93,798 93,798
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −17,006 17,006
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −9,715 26,721
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −34,091 60,812
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −15,723 76,535
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −12,690 89,225
2020-09-28 Principi Anthony Director Exercise or conversion · RSU −4,573 93,798
2020-06-04 Principi Anthony Director Grant or award · RSU +17,006 17,006
2019-06-26 Principi Anthony Director Grant or award · RSU +9,715 9,715
2018-06-29 Principi Anthony Director Grant or award · RSU +34,091 34,091
2017-06-13 Principi Anthony Director Grant or award · RSU +15,723 15,723
2016-06-10 Principi Anthony Director Grant or award · RSU +12,690 12,690
2015-09-01 Principi Anthony Director Grant or award +4,573 4,573

Page 1 of 1 · 13 trades